{
    "Trade/Device Name(s)": [
        "ATTEST Drug Screen Cup",
        "ATTEST Drug Screen Dip Card"
    ],
    "Submitter Information": "Advin Biotech, Inc.",
    "510(k) Number": "K201494",
    "Predicate Device Reference 510(k) Number(s)": [
        "K122809"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG",
        "DKZ",
        "DIO",
        "LCM",
        "NGG",
        "JXM",
        "DIS",
        "LDJ",
        "JXN",
        "DJR",
        "LFG",
        "DJC"
    ],
    "Summary Letter Date": "September 17, 2020",
    "Summary Letter Received Date": "August 10, 2020",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3650",
        "21 CFR 862.3100",
        "21 CFR 862.3250",
        "21 CFR 862.3620",
        "21 CFR 862.3610",
        "21 CFR 862.3170",
        "21 CFR 862.3700",
        "21 CFR 862.3150",
        "21 CFR 862.3910",
        "21 CFR 862.3870"
    ],
    "Regulation Name(s)": [
        "Opiate Test System",
        "Amphetamine Test System",
        "Cocaine and Cocaine Metabolite Test System",
        "Methadone Test System",
        "Methamphetamine Test System",
        "Benzodiazepines Test System",
        "Propoxyphene Test System",
        "Barbiturates Test System",
        "Tricyclic Antidepressant Drugs Test System",
        "Cannabinoids Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "6-Acetylmorphine",
        "d-Amphetamine",
        "Benzoylecgonine",
        "Buprenorphine",
        "EDDP",
        "d/l-Methadone",
        "d-Methamphetamine",
        "d/l-Methylenedioxymethamphetamine",
        "Morphine",
        "Nortriptyline",
        "Oxazepam",
        "Oxycodone",
        "Phencyclidine",
        "d-Propoxyphene",
        "Secobarbital",
        "THC-COOH"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Test Cup",
        "Dip Card"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunoassay",
        "Immunochromatographic assay",
        "Competitive binding"
    ],
    "Methodologies": [
        "Qualitative immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for ATTEST Drug Screen Cup and Dip Card, rapid immunoassays for qualitative detection of multiple drugs and metabolites in urine",
    "Indications for Use Summary": "For prescription use: rapid lateral flow immunoassays for qualitative detection of drugs and metabolites in human urine including 6-Acetylmorphine, amphetamines, benzoylecgonine, buprenorphine, EDDP, methadone, methamphetamine, MDMA, morphine, nortriptyline, oxazepam, oxycodone, phencyclidine, propoxyphene, secobarbital, and THC-COOH.",
    "fda_folder": "Toxicology"
}